Otozomal Resesif Distrofik Epidermolizis Bülozada Yaklaşım

Yaycıoğlu, Rana Altan; Akova, Yonca Aydın; Kaya, Fatma Selin; Oto, Sibel
March 2010
Turkish Journal of Ophthalmology / Turk Oftalmoloji Dergisi;Mar2010, Vol. 40 Issue 2, p107
Academic Journal
Purpose: To present the treatment approach to ocular complications in two cases with autosomal recessive dystrophic epidermolysis bullosa (EB) and to review the literature. Material and Method: Two teenage girls with EB, one with symblepharon (case 1) and the other with corneal opacity and vascularization (case 2) presented to our clinic. Case 1 had symblepharon, extending from the left upper eyelid to the superotemporal cornea, restricting the globe movements. During surgery, symblepharon lysis and lamellar keratectomy were followed by amniotic membrane transplantation to cover the cornea and palpebral conjunctiva. At presentation, case 2 was using artificial tears and topical cyclosporin A. The right eye had visual acuity of counting fingers, and opacity with superficial and deep vascularization in the lower third of the cornea. Topical bevacizumab and autologous serum were added to her treatment. Results: In Case 1, 63 months after surgery the eyelid margin was smooth and the eye was fully mobile. A mild symblepharon of the temporal conjunctiva in both eyes was present. Stromal thinning, superficial vascularization and opacification were significant in the temporal cornea. During the 8-month follow-up period of case 2, the visual acuity increased to 20/50. Slit-lamp examination showed a decrease in corneal opacity and vascularization. Discussion: According to our cases, alternative treatments such as amniotic membrane transplantation to treat symblepharon, and topical bevacizumab and autologous serum in intractable vascularization and opacity can be considered in cases of EB.


Related Articles

  • X-Linking Shows Promise Against Kerectasia. Hardten, David R. // Review of Ophthalmology;Apr2010, Vol. 17 Issue 4, p106 

    The article focuses on the application of collagen cross-linking procedure for corneal ectasia treatment. Clinical trials reveals disease progression in the untreated eyes and flattening in the treated eyes after the procedure. This suggests that the procedure can be effective, safe, and have...

  • Multicenter trial returns promising data on corneal cross-linking for ectatic corneas. Bechtel, Bryan // Ocular Surgery News;6/25/2010, Vol. 28 Issue 12, p44 

    The article discusses a multicenter clinical trial in the U.S. on corneal cross-linking for ectatic corneas, which found that the procedure improves vision and stops keratoconus and ectasia following laser-assisted in situ keratomileusis (LASIK). The researchers observed a reduction in corneal...

  • Effects of Cross-Linking on Visual Acuity in Patients with Keratoconus. Razmju, Hassan; Attarzadeh, Hossein; Raslan, Mohammad; Gharebash, Mostafa // Journal of Isfahan Medical School;Apr2013, Vol. 31 Issue 223, p9 

    Background: Keratoconus is a progressive disease occurring in adolescence or early twenties. In an eye with keratoconus, the cornea thins and bulges out into an irregular cone shape. Although keratoconus may be seen in one eye, in 90% of cases, both eyes are damaged. Cross-linking is a novel,...

  • Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis. Daniell, M.; Constantinou, M.; Vu, H. I.; Taylor, H. R. // British Journal of Ophthalmology;Apr2006, Vol. 90 Issue 4, p461 

    Aim: To evaluate the efficacy, safety, and therapeutic effect of topical ciclosporin A 0.05% as a steroid sparing agent in steroid dependent allergic conjunctivitis. Methods: Prospective, randomised, double masked, placebo controlled trial comparing signs, symptoms, and the ability to reduce or...

  • Management of Generalized Pruritus in Dominant Dystrophic Epidermolysis Bullosa Using Low-dose Oral Cyclosporin. Çalikoglu, Emel; Anadolu, Rana // Acta Dermato-Venereologica;Sep2002, Vol. 82 Issue 5, p380 

    Reports on the management of generalized pruritus in dominant dystrophic epidermolysis bullosa (DEB) using low-dose oral cyclosporin. Characteristics of DEB; Common symptoms of the condition.

  • Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin®) eye drops against corneal neovascularization. Koenig, Yanyan; Bock, Felix; Horn, Folkert; Kruse, Friedrich; Straub, Katja; Cursiefen, Claus // Graefe's Archive of Clinical & Experimental Ophthalmology;Oct2009, Vol. 247 Issue 10, p1375 

    To evaluate the short- and long-term in vivo safety and efficacy of topical bevacizumab (Avastin) application for treatment of corneal neovascularization secondary to a variety of corneal diseases. Thirty eyes of 27 patients with progressive corneal neovascularisation (not responding to...

  • Maternal Germline Mosaicism in Dominant Dystrophic Epidermolysis Bullosa. Cserhalmi-Friedman, Peter B; Garzon, Maria C; Guzman, Edwin; Martinez-Mir, Amalia; Chung, Wendy K; Anyane-Yeboa, Kwame; Christiano, Angela M // Journal of Investigative Dermatology;Nov2001, Vol. 117 Issue 5, p1327 

    Examines the maternal germline mosaicism in dominant dystrophic epidermolysis bullosa (DEB). Use of DNA from amniotic fluid for polymerase chain reaction amplification and automated sequencing; Presence of blistering and denuded areas at birth; Recessive form of DEB.

  • Amniotic membrane extract proving safe, effective in treatment of corneal epithelial defects. Cimberle, Michela; Mullin, David W. // Ocular Surgery News;3/25/2010, Vol. 28 Issue 6, p19 

    The article offers information on the AMX lyophilized human amniotic membrane extract from Keera, which is deemed effective in corneal epithelial defect treatment.

  • New hope for children with EB. HILTON, LISETTE // Dermatology Times;Jan2016, Vol. 37 Issue 1, p28 

    The article offers update on the phase three study of the drug Zorblisa from Scioderm as a potential topical treatment for children with epidermolysis bullosa (EB). Topics discussed are the importance of providing standard wound care to patients, the protection offered by nonstick and other...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics